Novel cardiac-specific biomarkers and the cardiovascular continuum.

Biomarker Insights
E VassiliadisM A Karsdal

Abstract

The concept of the cardiovascular continuum, introduced during the early 1990s, created a holistic view of the chain of events connecting cardiovascular-related risk factors with the progressive development of pathological-related tissue remodelling and ultimately, heart failure and death. Understanding of the tissue-specific changes, and new technologies developed over the last 25-30 years, enabled tissue remodelling events to be monitored in vivo and cardiovascular disease to be diagnosed more reliably than before. The tangible product of this evolution was the introduction of a number of biochemical markers such as troponin I and T, which are now commonly used in clinics to measure myocardial damage. However, biomarkers that can detect specific earlier stages of the cardiovascular continuum have yet to be generated and utilised. The majority of the existing markers are useful only in the end stages of the disease where few successful intervention options exist. Since a large number of patients experience a transient underlying developing pathology long before the signs or symptoms of cardiovascular disease become apparent, the requirement for new markers that can describe the early tissue-specific, matrix remodelling process...Continue Reading

References

Nov 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·G S HerronR J Stoney
Dec 14, 1990·Biochemical and Biophysical Research Communications·Y KambayashiH Imura
Mar 3, 1988·Nature·T SudohH Matsuo
May 1, 1995·European Heart Journal·J E Bishop, G J Laurent
Jun 1, 1995·Journal of Cardiovascular Risk·M SeedP Stubbs
Jan 1, 1994·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J R HedgesJ R Swanson
Mar 27, 1995·Annals of the New York Academy of Sciences·J E BishopW S Stirewalt
Dec 22, 1993·Molecular and Cellular Biochemistry·V PelouchN S Dhalla
May 1, 1996·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M M ThompsonP R Bell
Dec 31, 1997·Current Opinion in Lipidology·B Angelin
Aug 12, 1998·The Journal of Surgical Research·K BaghelaiA S Wechsler
Mar 12, 1999·The American Journal of Cardiology·C A PolanczykP A Johnson
Apr 24, 1999·Experimental Nephrology·S R Rittling, D T Denhardt
Dec 5, 2000·Matrix Biology : Journal of the International Society for Matrix Biology·C M Giachelli, S Steitz
Dec 13, 2000·The American Journal of Cardiology·T V StörkUNKNOWN North-Wurttemberg Infarction Study (NOWIS) Group
Dec 21, 2000·Current Atherosclerosis Reports·J D Morrisett
Jan 21, 2001·The Journal of Biological Chemistry·Y OkamuraJ F Strauss
Sep 15, 2001·Mechanisms of Ageing and Development·M L BurgessH L Hedrick
May 25, 2002·The British Journal of Surgery·Ian M LoftusM M Thompson
Oct 31, 2002·Circulation·Lauren J KimPeter J Pronovost
Apr 10, 2003·Mayo Clinic Proceedings·Brian P ShapiroMargaret M Redfield
Dec 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Rainer H Böger
Mar 23, 2004·European Heart Journal·Ramón Arroyo-EspligueroJuan Carlos Kaski
Mar 24, 2004·Critical Reviews in Oncology/hematology·François-Xavier MaquartJean-Claude Monboisse
Mar 24, 2004·Critical Reviews in Oncology/hematology·Georges BellonArnaud Robinet
Apr 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Claudia MonacoMarc Feldmann

❮ Previous
Next ❯

Citations

Dec 25, 2013·Psychosomatic Medicine·Ellen Alison HolmanDaniele Piomelli
Feb 1, 2013·Revista Española De Cardiología·Enrique GalveUNKNOWN Working Group on Vascular Risk, Cardiac Rehabilitation of the Spanish Society of Cardiology
Feb 1, 2015·Matrix Biology : Journal of the International Society for Matrix Biology·J Michael WellsJ Edwin Blalock
Aug 30, 2013·Neonatal Network : NN·Daniele Ottinger, Patricia Nash
Jan 27, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Gehan Mostafa Hamed, Mona Fathey Abdel Fattah
Jan 4, 2018·Hypertension·Madeleine JohanssonArtur Fedorowski
Nov 12, 2013·Expert Review of Proteomics·Andrew J PercyChristoph H Borchers
Sep 21, 2017·Heart·Syed Km GardeziSaul G Myerson
Jul 28, 2020·Journal of Toxicology·Olufunke Esan OlorundareHasan Mukhtar
Nov 19, 2020·International Journal of Molecular Sciences·Rui Song, Lubo Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.